The EVI2A gene helps make a small protein found on the surface of cells, where it supports normal cell signaling and growth. Some people first learn about this gene when testing looks closely at the NF1 region linked to neurofibromatosis type 1. If EVI2A is lost as part of a larger missing piece of chromosome 17, it can appear along with the genetic changes that cause neurofibromatosis type 1 and related features.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or managing processes in the body. Some carry the code for proteins, which do much of the work inside cells. Others are involved mainly in regulating when certain processes happen, where they happen, and how active they are. Taken together, genes affect how your body develops and works, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
EVI2AGene function
What if the gene works
The EVI2A gene makes a protein found on the cell surface. It may help cells communicate and support normal growth.
Risk
What if the gene does not work
Changes in the EVI2A gene may alter how much EVI2A protein cells make or how it interacts with nearby signaling partners at the cell surface. Effects can range from mild to more disruptive, with variable impact on cell signaling.
Treatment
What does that mean for your treatment
No EVI2A-specific treatment or management approach is currently established for pathogenic or loss-of-function variants in the EVI2A gene.
Gene function
What if the gene works
Many of your cells use EVI2A as part of their outer surface, where they stay in contact with the world around them. Understanding what the EVI2A gene does in the body helps show how cells manage everyday communication and steady activity.
The EVI2A gene makes a protein that sits in the cell membrane, the thin outer layer around a cell. This location allows it to take part in how cells connect with their immediate surroundings.
Because its protein is placed at the cell surface, EVI2A is involved in normal cell signaling and communication. These messages help cells coordinate routine activity and respond to nearby cues in a controlled way.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help create normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. At times, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
EVI2A gene variants can change how much EVI2A protein a cell makes or alter the shape of this cell membrane protein, which may reduce its stability, surface placement, or interactions with other proteins. This is the main way experts describe how EVI2A gene variants affect function at the cellular level. Milder variants may partly lower protein activity, while more severe splice or truncating variants can greatly reduce or eliminate the protein.
How variants are linked to conditions
Variants in the EVI2A gene do not yet have a broadly confirmed link to a specific health condition, so information about EVI2A gene variants and disease may change as research develops. Some studies have explored possible links, but no single EVI2A related condition is widely accepted in medical genetics. If you carry a confirmed variant in the EVI2A gene, personal guidance from your doctor or genetic counselor is the most useful way to interpret it.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm the diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to EVI2A. Anyone with concerns about their personal risk should speak with a doctor or genetic counselor.
Inheritance of EVI2A variants
There is not yet a broadly confirmed, disease-specific inheritance pattern for the EVI2A gene, so how EVI2A gene variants are inherited is not defined in the same clear way as for well-established dominant or recessive conditions. As research develops, this may become clearer. The EVI2A gene is located on chromosome 17, which is an autosome, so each person inherits one copy from their mother and one copy from their father.
What does my EVI2A result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for EVI2A. If you have a specific EVI2A result and want to understand what it could mean for relatives, a doctor or genetic counselor can help explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
To find variants in the EVI2A gene, labs usually analyze DNA from a blood sample or saliva using sequencing, sometimes as part of a multigene panel or a broader exome test. This kind of EVI2A genetic testing checks the gene’s code for small changes and, in some tests, larger missing or extra pieces.
When should I consider getting a genetic test?
There is not a broadly established reason to order genetic testing just for the EVI2A gene. Decisions about testing are usually based on your health history, symptoms, and family history, and are best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and on the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most helpful when considered along with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment works well for one person, seems weaker in another, or causes more side effects in someone else. These differences are common and are one part of why medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can shape the way a person responds to medications. It examines gene-drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support more informed and more personalized treatment decisions. For a closer look at this topic, more information is available in the LearnHub.
Drugs influenced by the EVI2A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general questions about medicines, side effects, or your health are best discussed with your doctor.
History
In the late 1980s and early 1990s, researchers studying the chromosome 17 region linked to neurofibromatosis type 1 identified the EVI2A gene within a large stretch of DNA that was being mapped in detail. Initially understood only through gene mapping work, EVI2A was recognized as an unusual finding because it sits inside an intron, a noncoding segment, of the nearby NF1 gene. From these first observations, research expanded steadily as scientists worked out its position, structure, and relationship to neighboring genes. Its discovery helped illustrate how complex the human genome can be, with one gene located inside another gene’s larger sequence. Over time, descriptions became more precise as genome studies refined the picture.